Dr. Sandra Amaral, United States
Biopsy Findings from the VIRTUUS Study by Center Surveillance Practices: A North American Cohort of Incident Kidney Transplant Recipients
Dr. Massimiliano Bertacchi, Switzerland
Donor-Derived Specific Lymphocyte T-cell Therapy for Refractory Post-Transplant BK Virus Nephritis in a child, a single center experience
Dr. Ruby Patel, United States
GFR stabilizes and donor specific antibody levels fall after adding belatacept to a low dose tacrolimus/ mycophenolate/ prednisone regimen in nonadherent pediatric and adolescent kidney transplant recipients
Dr. Moran Plonsky Toder, Israel
Genetic Analysis in Pediatric Kidney Transplantation: Insights from a Decade of Experience at a Northern Israeli Referral Center
Dr. Ben C Reynolds, United Kingdom
2 year follow-up of a pediatric kidney transplant recipient from a donor with known autosomal dominant polycystic kidney disease
Dr. Longshan Liu, People's Republic of China
De Novo Use of tacrolimus granules in pediatric kidney transplant recipients: Integrated safety and efficacy results from two multicenter open-label studies in China
Dr. Khaoula Talbi, Germany
Endothelial p16INK4a knockout improves kidney outcome in experimental models of ischemia reperfusion injury and transplantation
Dr. Philipp Tischer, Germany
Treatment of acute antibody-mediated rejection after kidney transplantation targeting CD38: Two cases from two European centres
Dr. Alejandro Zarauza Santoveña, Spain
Successful treatment of relapsing focal and segmental glomerulosclerosis using immunoadsorption and B-cell targeted therapy
Dr. Maria Teresa Ludovica Viganoni, Italy
Cytomegalovirus infection in first year after pediatric renal transplantation: a ten year single center experience